These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 29198562)

  • 21. [Epidemiology of Alcoholic Liver Disease in Korea].
    Lee SW
    Korean J Gastroenterol; 2020 Aug; 76(2):55-59. PubMed ID: 32839366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis.
    Williams R; Aspinall R; Bellis M; Camps-Walsh G; Cramp M; Dhawan A; Ferguson J; Forton D; Foster G; Gilmore I; Hickman M; Hudson M; Kelly D; Langford A; Lombard M; Longworth L; Martin N; Moriarty K; Newsome P; O'Grady J; Pryke R; Rutter H; Ryder S; Sheron N; Smith T
    Lancet; 2014 Nov; 384(9958):1953-97. PubMed ID: 25433429
    [No Abstract]   [Full Text] [Related]  

  • 23. Alcohol consumption and non-communicable diseases: epidemiology and policy implications.
    Parry CD; Patra J; Rehm J
    Addiction; 2011 Oct; 106(10):1718-24. PubMed ID: 21819471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in the management and burden of alcoholic liver disease.
    Mathurin P; Bataller R
    J Hepatol; 2015 Apr; 62(1 Suppl):S38-46. PubMed ID: 25920088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tackling the epidemic: the NCEPOD report on alcohol-related liver disease and the Lancet Commission on Liver Disease.
    Kiat C; O'Mahony S
    J R Coll Physicians Edinb; 2018 Dec; 48(4):291-292. PubMed ID: 30488880
    [No Abstract]   [Full Text] [Related]  

  • 26. The cost-effectiveness of testing for hepatitis C in former injecting drug users.
    Castelnuovo E; Thompson-Coon J; Pitt M; Cramp M; Siebert U; Price A; Stein K
    Health Technol Assess; 2006 Sep; 10(32):iii-iv, ix-xii, 1-93. PubMed ID: 16948891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growing burden of alcoholic liver disease in China: A review.
    Wang WJ; Xiao P; Xu HQ; Niu JQ; Gao YH
    World J Gastroenterol; 2019 Mar; 25(12):1445-1456. PubMed ID: 30948908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The economic cost of preventable disease in Australia: a systematic review of estimates and methods.
    Crosland P; Ananthapavan J; Davison J; Lambert M; Carter R
    Aust N Z J Public Health; 2019 Oct; 43(5):484-495. PubMed ID: 31390112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic costs of excessive alcohol consumption in the U.S., 2006.
    Bouchery EE; Harwood HJ; Sacks JJ; Simon CJ; Brewer RD
    Am J Prev Med; 2011 Nov; 41(5):516-24. PubMed ID: 22011424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The undertreatment of alcohol-related liver diseases among people with alcohol use disorder.
    Scafato E; Caputo F; Patussi V; Balbinot P; Addolorato G; Testino G
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):974-982. PubMed ID: 32017006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health and economic burden of the projected obesity trends in the USA and the UK.
    Wang YC; McPherson K; Marsh T; Gortmaker SL; Brown M
    Lancet; 2011 Aug; 378(9793):815-25. PubMed ID: 21872750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health economics of weight management: evidence and cost.
    Kouris-Blazos A; Wahlqvist ML
    Asia Pac J Clin Nutr; 2007; 16 Suppl 1():329-38. PubMed ID: 17392129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alcoholic liver disease - the extent of the problem and what you can do about it.
    Hazeldine S; Hydes T; Sheron N
    Clin Med (Lond); 2015 Apr; 15(2):179-85. PubMed ID: 25824072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Projected prevalence and mortality associated with alcohol-related liver disease in the USA, 2019-40: a modelling study.
    Julien J; Ayer T; Bethea ED; Tapper EB; Chhatwal J
    Lancet Public Health; 2020 Jun; 5(6):e316-e323. PubMed ID: 32504584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The health and economic burden of smoking in 12 Latin American countries and the potential effect of increasing tobacco taxes: an economic modelling study.
    Pichon-Riviere A; Alcaraz A; Palacios A; Rodríguez B; Reynales-Shigematsu LM; Pinto M; Castillo-Riquelme M; Peña Torres E; Osorio DI; Huayanay L; Loza Munarriz C; de Miera-Juárez BS; Gallegos-Rivero V; De La Puente C; Del Pilar Navia-Bueno M; Caporale J; Roberti J; Virgilio SA; Augustovski F; Bardach A
    Lancet Glob Health; 2020 Oct; 8(10):e1282-e1294. PubMed ID: 32971051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Missed opportunities for intervention in alcohol-related liver disease in the UK.
    Burton R; Sheron N
    Lancet Gastroenterol Hepatol; 2017 Jul; 2(7):469-471. PubMed ID: 28606872
    [No Abstract]   [Full Text] [Related]  

  • 38. Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH).
    Arab JP; Roblero JP; Altamirano J; Bessone F; Chaves Araujo R; Higuera-De la Tijera F; Restrepo JC; Torre A; Urzua A; Simonetto DA; Abraldes JG; Méndez-Sánchez N; Contreras F; Lucey MR; Shah VH; Cortez-Pinto H; Bataller R
    Ann Hepatol; 2019; 18(3):518-535. PubMed ID: 31053546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The alcohol harm paradox: using a national survey to explore how alcohol may disproportionately impact health in deprived individuals.
    Bellis MA; Hughes K; Nicholls J; Sheron N; Gilmore I; Jones L
    BMC Public Health; 2016 Feb; 16():111. PubMed ID: 26888538
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.